Company / Tangible Book Value per Share
Ligand Pharmaceuticals, Inc. Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$47.93
FY2025
5-year range
$35.25 / $47.93
FY2021-FY2025
Trend
+16.0%
vs FY2024
Sector context
#8 of 209
Health Care
What the data says
Among 209 Health Care companies, Ligand Pharmaceuticals, Inc. is in the top 4% for tangible book value per share. Tangible Book Value per Share has fluctuated over the past 10 years, ranging from $13.49 in FY2016 to $47.93 in FY2025.
Based on SEC 10-K filings.
47.93 in FY2025 with a 5-year CAGR of +9.2%. Top quartile in the Health Care sector.
Improved from $35.25 to $47.93 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- +10.4%
- 5-Year CAGR
- +9.2%
- 10-Year CAGR
- -
Sector benchmark
-48.7% below sector average
Key checks
Key Insights
- In FY2025, tangible book value per share increased 16.0% year-over-year.
- Ranks #8 out of 209 companies in the Health Care sector.
- Lowest tangible book value per share in the period was in FY2016.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $47.93 | +16.0% |
| FY2024 | $41.31 | +17.2% |
| FY2023 | $35.25 | -1.1% |
| FY2022 | $35.63 | -19.9% |
| FY2021 | $44.50 | +44.0% |
| FY2020 | $30.90 | -4.5% |
| FY2019 | $32.36 | +44.3% |
| FY2018 | $22.43 | +49.4% |
| FY2017 | $15.01 | +11.3% |
| FY2016 | $13.49 | +17.3% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026